Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for…
Articles by Marisa Wexler, MS
Note: This story was updated on June 21, 2021, to clarify that these genetic tests are after a baby’s…
A decision from England’s National Institute for Health and Care Excellence (NICE) will make Spinraza (nusinersen) available to people…
Newborn screening can aid in the early diagnosis and prompt treatment of spinal muscular atrophy (SMA), which can lead…
The European Alliance for Newborn Screening for Spinal Muscular Atrophy is calling on all European states to introduce routine screening…
Treatment with Spinraza (nusinersen) may cause some alterations in the cerebrospinal fluid — that which surrounds the brain and…
Being an adolescent or young adult with spinal muscular atrophy (SMA) presents unique challenges, according to a study based…
Improvement in motor function, breathing, and ease of administration are among the factors that people with spinal muscular atrophy…
A free resource booklet, published by Cure SMA, may help people with spinal muscular atrophy (SMA) to better understand the…
Health Canada has approved Novartis‘ gene therapy Zolgensma (onasemnogene abeparvovec) to treat pediatric spinal muscular atrophy (SMA) patients…